Chris Slavinsky

Chris Slavinsky currently serves as the Chief Business Development & Legal Officer at HanAll Biopharma since July 2024. Previously, Chris held the position of Chief Business and Legal Officer at Coherus BioSciences, where responsibilities included transitioning the company into novel immuno-oncology therapeutics. Prior experience includes roles at Pharmacosmos Therapeutics as General Counsel, Prometheus Biosciences as General Counsel and Head of Business Development, and leadership positions at Takeda and Pfizer, focusing on business development and transactional legal support. Chris's educational credentials include a JD from Washington University in St. Louis School of Law, an MS in Biochemistry from Thomas Jefferson University, and a BS in Biochemistry from Stony Brook University.